# Safety and Efficacy of Fecal Microbiota Transplantation

> **NCT04014413** · NA · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 450 (estimated)

## Conditions studied

- Crohn Disease
- Ulcerative Colitis
- Celiac Disease
- Irritable Bowel Syndrome
- Functional Dysphonia
- Constipation
- Clostridium Difficile Infection
- Diabetes Mellitus
- Obesity
- Multidrug -Resistant Infection
- Hepatic Encephalopathy
- Multiple Sclerosis
- Pseudo-Obstruction
- Carbapenem-Resistant Enterobacteriaceae Infection
- Vancomycin Resistant Enterococci Infection
- Multiple Organ Dysfunction Syndrome
- Dysbiotic Bowel Syndrome
- MRSA Enteritis
- Pseudomembranous Enterocolitis
- Alopecia
- Autism
- Graft-versus-host Disease
- Idiopathic Thrombocytopenic Purpura
- Atopy or Allergy
- Liver Disease
- Alcohol Dependence
- Psoriatic Arthropathy

## Interventions

- **PROCEDURE:** Fecal Microbiota Transplantation

## Key facts

- **NCT ID:** NCT04014413
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-07-15
- **Primary completion:** 2030-10-31
- **Final completion:** 2030-10-31
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2024-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04014413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04014413, "Safety and Efficacy of Fecal Microbiota Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04014413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*